Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 7, 2010, Pages 929-936

  Sermet Gaudelus, Isabelle ^a,b   Girodon, Emanuelle ^c   Sands, Dorota ^d   Stremmler, Nathalie ^e   Vavrova, Vera ^f   Deneuville, Eric ^g   Reix, Philippe ^h   Bui, Stéphanie ⁱ   Huet, Frédéric ^j   Lebourgeois, Muriel ^a   Munck, Anne ^k   Iron, Albert ⁱ   Skalicka, Veronika ^f   Bienvenu, Thierry ^l   Roussel, Delphine ^b   Lenoir, Gérard ^a   Bellon, Gabriel ^h   Sarles, Jacques ^e   Macek, Milan ^f   Roussey, Michel ^g   Fajac, Isabelle ^l   Edelman, Aleksander ^b   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d INSTITUTE OF MOTHER AND CHILD   (Poland)

^e TIMONE HOSPITAL   (France)

^f UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^g SERVICE DE RHUMATOLOGIE   (France)

^h HÔPITAL DEBROUSSE   (France)

ⁱ HÔPITAL PELLEGRIN   (France)

^j HÔPITAL DU BOCAGE   (France)

^k HÔPITAL ROBERT DEBRÉ   (France)

^l NONE   (France)

more..

Author keywords

CFTR related disorders; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator (CFTR); Nasal potential difference

Indexed keywords

CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BRONCHIECTASIS; CHILD; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; GENOTYPE; HUMAN; INFANT; MEMBRANE CONDUCTANCE; NOSE MUCOSA; PHENOTYPE; POTENTIAL DIFFERENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; SWEAT TEST; CASE CONTROL STUDY; CHEMISTRY; CYSTIC FIBROSIS; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PREDICTION AND FORECASTING; REPRODUCIBILITY; SWEAT;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; GENOTYPE; HUMANS; INFANT; NASAL MUCOSA; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SWEAT;

EID: 77958180032     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201003-0382OC     Document Type: Article

References (33)

1. Rowe S, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005;352:1992-2001.
2. Rosenstein BJ, Cutting GR; Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:689-695.
3. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-S14.
4. Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003;9:498-503.
5. Noone PG, Knowles MR. "CFTR-opathies": disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001;2:328-332.
6. Kerem E. Atypical CF and CF related diseases. Paediatr Respir Rev 2006;7:S144-S146.
7. Southern KW. Cystic fibrosis and formes frustes of CFTR-related disease. Respiration 2007;74:241-251.
8. Castellani C, Cuppens H, Macek M Jr, Cassiman JJ, Kerem E, Durie P, Tullis E, Assael BM, Bombieri C, Brown A, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008;7:179-186.
9. Sermet-Gaudelus I, Déchaux M, Vallée B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, et al. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes. Am J Respir Crit Care Med 2005;171:1026-1031.
10. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1993;6:445-455.
11. Taylor CJ, Hardcastle J, Southern KW. Physiological measurements confirming the diagnosis of cystic fibrosis: the sweat test and measurements of transepithelial difference. Paediatr Respir Rev 2009;10:220-226.
12. Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, Bentur L, Yahav Y, Springer H, Kramer MR, et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001;17:1208-1215.
13. Delmarco A, Pradal U, Cabrini G, Bonizzato A, Mastella G. Nasal potential difference in cystic fibrosis patients presenting borderline sweat test. Eur Respir J 1997;10:1145-1149. (Pubitemid 27201823)
14. Jaron R, Yaakov Y, Rivlin J, Blau H, Bentur L, Yahav Y, Kerem E, Bibi H, Picard E, Wilschanski M. Nasal potential difference in non-classic cystic fibrosis: long term follow-up. Pediatr Pulmonol 2008;43:545-549.
15. Goubau C, Wilschanski M, Skalická V, Lebecque P, Southern KW, Sermet I, Munck A, Derichs N, Middleton PG, Hjelte L, et al. Phenotypic characterization of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax 2009;64:683-691.
16. Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A. The CF-CIRC Study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. BMC Pediatr 2006;6:25-30.
17. Sermet-Gaudelus I, Girodon E, Huet F, Aboutaam R, Bui S, Deneuville E, Bellon G, Lenoir G, Edelman A. Nasal potential difference in cystic fibrosis diagnosis of very young children. J Pediatr 2007;150:e34-e35.
18. Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F, Goossens M. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 1992;13:770-776.
19. Le Maréchal C, Audrézet MP, Quéré I, Raguénès O, Langonné S, Férec C. Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet 2001;108:290-298.
20. Audrézet MP, Chen JM, Raguénès O, Chuzhanova N, Giteau K, Le Maréchal C, Quéré I, Cooper DN, Férec C. Genomic rearrangements in the CFTR gene: extensive allelic heterogeneity and diverse mutational mechanisms. Hum Mutat 2004;23:343-357.
21. Niel F, Martin J, Dastot-Le Moal F, Costes B, Boissier B, Delattre V, Goossens M, Girodon E. Rapid detection of CFTR gene rearrangements impacts on genetic counselling in cystic fibrosis. J Med Genet 2004;41:e118.
22. De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, Sinaasappel M; Diagnostic Working Group. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006;61:627-635.
23. Morice AH, Kastelik JA. Chronic cough in adults. Thorax 2003;58:901-907.
24. Lebecque P, Leal T, De Boeck C, Jaspers M, Cuppens H, Cassiman JJ. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children. Am J Respir Crit Care Med 2002;165:757-761.
25. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC. Standards for reporting of diagnostic accuracy towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative. Clin Chem 2003;49:1-6.
26. Southern KW, Noone PG, Bosworth DG, Legrys VA, Knowles MR, Barker PM. A modified technique for measurement of nasal transepithelial potential difference in infants. J Pediatr 2001;139:353-358.
27. Clain J, Lehmann-Che J, Duguépéroux I, Arous N, Girodon E, Legendre M, Goossens M, Edelman A, de Braekeleer M, Teulon J, et al. Misprocessing of the CFTR protein leads to mild cystic fibrosis phenotype. Hum Mutat 2005;25:360-371.
28. Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, Boissier B, Bassinet L, Fichou Y, des Georges M, Stanke F, et al. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 2009;30:1093-1103.
29. Fajac I, Viel M, Gaitch N, Hubert D, Bienvenu T. Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease. Eur Respir J 2009;34:772-773.
30. Bienvenu T, Sermet-Gaudelus I, Burgel PR, Hubert D, Crestani B, Bassinet L, Dusser D, Fajac I. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2010;181:1078-1084.
31. Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, Martin S, Corey M, Tsui LC, Durie P. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. Am J Respir Crit Care Med 2006;174:787-794.
32. Knowles MR, Durie PR. What is cystic fibrosis? N Engl J Med 2002;347:439-442.
33. Paranjape SM, Zeitlin PL. Atypical cystic fibrosis and CFTR-related diseases. Clin Rev Allergy Immunol 2008;35:116-123.